The Innovation Fund Noord-Holland has awarded a subsidy to a collaborative project between the Amsterdam biotech start-up SanaGen B.V. and the research groups of Joost Verhaagen from the NIN and Jan Voorberg from Sanquin.
This grant supports the development of gene therapy for rare bleeding disorders. This collaborative project is co-financed by the PPP allowance from the Top Sector Life Sciences & Health.
The Top Sector Life Sciences & Health stimulates innovative research by guiding and supporting public-private partnerships in the Life Sciences & Health sector.
More information about the funding can be found on the website of SanaGen.